Clinical Trial Update: The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia

View source ↗

Summary

Terminated observational study evaluating paliperidone ER in schizophrenia, focusing on economic, functional, and clinical outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega ER (paliperidone extended-release)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Schizophrenia | Status: TERMINATED